openPR Logo
Press release

CAR T Cell Therapy Market to Grow at a High CAGR of 32.5 % Till 2026 By Key Players Pfizer Inc, Novartis International AG, Kite Pharma, Inc. (Gilead Sciences Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio Inc.

12-04-2018 03:04 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

CAR T Cell Therapy

CAR T Cell Therapy

Increasing incidence of cancer and rising number of patients showing response failure to alternative treatments is expected to foster growth of the global CAR-T cell therapy market. Rising number of adults and children developing cancer is expected to lead to high demand for an effective and reliable therapeutic treatment approach for improvement of quality of patient’s lives. The Cancer Research UK reported that over 14.1 million cancer cases occurred in 2012 across the world. Moreover, according to the Leukemia and Lymphoma Society of Canada, around 22,340 people in Canada were diagnosed with some form of blood cancer, of which 9,000 cases were lymphoma.

Download PDF Brochure of This Business Research Report :

Moreover, development of new and effective therapy options to cure symptoms of the disease is also a vital factor contributing to growth of CAR-T cell therapy market. In 2017, the U.S. Food and Drug Administration approved two CAR-T cell therapies Kymriah and Yescarta for children and adult lymphoblastic leukemia and advanced lymphoma in adults, respectively. This is expected to aid in growth of the market over the forecast period.

Market Dynamics

CAR-T cell therapy is expected to be an important development in cancer treatment and therapeutics industry due to its cost efficiency. Moreover, rising incidence of cancer is leading to high demand for its treatment. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were reported worldwide, in 2012. As per WCRFI, it is projected that by 2035, around 24 million cancer cases would be observed worldwide. Moreover, introduction of new therapies into the market is further expected to bolster growth of CAR-T cell therapy market. For instance, in October 2017, the U.S. Food and Drug Administration granted marketing approval to Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma.

Key features of the study:

-This report provides in-depth analysis of CAR-T cell therapy market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2017 – 2028), considering 2017 as the base year
-It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
-This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
-It profiles leading players in the global CAR-T cell therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans

Competitive Analysis

Key companies covered as a part of this study includes Novartis International AG, Kite Pharma, Inc. (Gilead Sciences, Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio, Inc. (Celgene Corporation), Sorrento Therapeutics Inc., Mustang Bio, Inc., Aurora Biopharma Inc., Legend Biotech (Genscript Biotech Corporation), Pfizer, Inc. and CARsgen Therapeutics, Ltd.

Request For Customization Of This Business Research Report :

Detailed Segmentation:

Global CAR-T Cell Therapy Market, by Targeted Antigen:
CD 19
CD 20

Global CAR-T Cell Therapy Market, by Therapeutic Application:
Acute Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Diffuse Large B-cell Lymphoma (DLBCL)
Follicular Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Acute Myeloid Leukemia
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal Cancer

In terms of market size, North America is dominant in the global CAR-T cell therapy market. This is attributed to rapid development and launch of new therapies for the treatment of cancer by key players in the market in the region. For instance, in August 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah, a CAR-T cell therapy to treat pediatric and young adult patients suffering with a form of acute lymphoblastic leukemia. Moreover, a large patient pool suffering from cancer in the U.S. and Canada is expected to further support growth of region in the global market. For instance, according to the Centers of Disease Control and Prevention (CDC) 2016, around 171,000 patients with blood cancer are diagnosed each year in the U.S. Europe is expected to be the second most prominent market, in terms of revenue, owing to rising investment and extensive research for development of cancer therapies in the region.

For instance, the European Hematology and Oncology department published an undergoing study in 2017 that states the role of CAR-T cells in treatment of Leukapheresis. Furthermore, Asia Pacific is expected to exhibit highest growth over the forecast period, owing to increasing number of global players collaborating and signing research as well as manufacturing contracts for CAR-T cell therapies with local players in the region. For instance, Cesca Therapeutics signed a license agreement with China-based, Boyalife Group, in March 2018, for CAR-T cell related bioprocessing, development, and manufacturing outsourcing.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CAR T Cell Therapy Market to Grow at a High CAGR of 32.5 % Till 2026 By Key Players Pfizer Inc, Novartis International AG, Kite Pharma, Inc. (Gilead Sciences Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio Inc. here

News-ID: 1416591 • Views: 1338

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases

More Releases for CAR

Car Monitor Display Global Car Monitor Display Market Insights, Forecast to 2025 This report presents the worldwide Car Monitor Display market size value, production and consumption, splits the breakdown data status 20132018 and forecast to 2025, by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porters Five Forces Analysis. Download Free PDF Sample
Sports Car Industry Forecasts
Albany, New York, November 8, 2016: Market Research Hub has announced a new research report to its database, titled “Sports Car industry forecasts”. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far
India Car Rental Market
A research study, titled “India Car Rental Market: Trends, Opportunities And Forecasts (2016-2021)” - (By Value, By Region, By Segment - Radio Taxi, Corporate Rental, Aggregators and Affilators; Key Players; Market Share And Dynamics),” has been recently added by to its huge repository of research studies. The research study further provides a detailed analysis of the car rental market in India, focusing on the product segmentation, competitive scenario, and
Apple Car
Apple Car – The new Apple driverless car was unveiled it is said to be the top hybrid electric car. The Apple Car will change the automotive industry very soon, learn why, & discover what the Apple Driverless Car will contain. Apple Car - All over, an auto appears like a heartbreaking thing for Apple Inc. to manufacture. Autos are a fiercely commoditised, staggeringly costly, for the most part low-edge
Connected World - Connected Car
According to ABI research, the number of global users of telematics smartphone applications is set to explode in the next five years from 3.2 million to 129 million users. It is vital that automotive manufacturers keep up-to-date with developments in this field if they are to remain competitive in this fast-paced market. Because their customers won’t wait. At IQPC’s 4th International Conference Connected Vehicles from 12-14 April in Berlin, experts
Car insurance: Over 50 car insurance advantages
Over 50 car insurance It has been observed that older drivers tend to have a more mature approach towards driving than new drivers. Car insurance companies are more and more eager to target drivers aged 50 plus or those that have retired as older drivers are more experience, fewer accidents and more consistent. We can say older drivers are present less of a risk. This means the over 50s are less